Anondita Medicare Limited shareholders have approved all seven resolutions placed before the Extra-Ordinary General Meeting (EGM) held on May 28, 2026. The meeting, conducted via Video Conference, saw the passage of special and ordinary resolutions concerning capital raising, related party transactions, and managerial remuneration.

The scrutinizer's report submitted by Mr. Mohit Singhal, Practicing Company Secretary, confirmed that the resolutions were passed with the requisite majority. The key agenda items included the issue of warrants convertible into equity shares to persons belonging to the promoter category on a preferential basis. Shareholders also approved material related party transactions with Anondita Healthcare & Rubber Products (India) Limited and Mr. Anupam Ghosh for the financial year 2026-27, alongside the ratification of prior transactions with the former entity.

Voting Outcomes

The voting results indicated strong support for the management's proposals. For the special resolution regarding the issuance of warrants, 11 members cast 11,372,595 votes in favour, representing 100% of the votes polled. Similarly, the special resolution to amend the main object clause of the Memorandum of Association received 11,372,595 votes in favour, also constituting 100% of the votes polled.

Resolutions concerning managerial remuneration for Mr. Reshant Ghosh, Whole Time Director, and Mr. Anupam Ghosh, Managing Director, were passed with identical margins. Each of these special resolutions secured 11,372,595 votes in favour.

Related Party Transactions

Three ordinary resolutions related to related party transactions were approved with 100% assent from eligible voters. Promoters were ineligible to vote on these resolutions pursuant to Regulation 23(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Consequently, the votes were cast by nine eligible members, totalling 116,002 votes in favour for each resolution.

The table below summarizes the voting results for the key resolutions:

The remote e-voting process was managed by National Securities Depository Limited (NSDL), with the platform open from May 25 to May 27, 2026. A total of 11 members participated in the e-voting process.

Anondita Medicare Limited has secured its first export purchase order worth approximately ₹43.14 crore from Supra Healthcare Johannesburg (Pty) Ltd., South Africa, under the South African Government condom procurement program. This order marks the company's entry into the South African market and validates its manufacturing capabilities. The supplies are expected to be executed by September 30, 2026, strengthening the company's export business.

Order Details

The order comprises the supply and delivery of male condoms equivalent to 50 containers (40-foot containers). This transaction represents a significant milestone as it is the first export purchase order received under the approved South African tender framework. The company was approved as a manufacturer for the supply and delivery of condoms under the said tender for the period commencing from November 1, 2025 and ending on October 31, 2030.

Management Commentary

Mr. Anupam Ghosh, Managing Director, Anondita Medicare Limited, stated that securing the order validates the company's manufacturing excellence and global quality standards. He added that this achievement will enhance the company's presence in international institutional markets.

Company Overview

Anondita Medicare Limited is a manufacturer of condoms and sexual wellness products, operating under the flagship brand “COBRA.” The company focuses on automation-led capacity enhancement and holds certifications including ISO 9001:2015 and ISO 13485:2016.